In Nice, Circum Medtech Pharma is making the Medtech value chain more agile, more reliable, and more efficient
Circum Medtech Pharma is an innovative company launched in 2024, operating as a CDMO (Contract Development and Manufacturing Organization) in the field of medical devices. Headquartered in Nice, at the heart of the international Grand Arénas business district, with an industrial site in Tunisia and a strategic foothold in Switzerland, the company combines experience, agility, […]
Unlocking Life Sciences Opportunities in the South of France
Team Nice Côte d’Azur is organizing a Life Sciences Investment event ‘Unlocking Life Sciences opportunities in the South of France‘ on April 23 in Nice. Don’t miss the chance to unlock new business opportunities and explore high-impact investments in Life Sciences in the Côte d’Azur! This event, co-organized by Team Nice Côte d’Azur, SIC Venture […]
Christophe Mossé appointed as CEO of Arkopharma group
Key Points Christophe Mossé appointed as CEO of Arkopharma group He will oversee Arkopharma’s activities and related activities of Dermapharm Group. Brings industry expertise from leading groups: Naos, Galderma, Novartis,… Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements. Arkopharma, a European leader in […]
Nucleate France UniCA strengthens the ties between research, industry, and entrepreneurship in life sciences.
The opening of a Nucleate branch in Nice is an incredible opportunity for our territory. This international program, initiated by students from Harvard Medical School and present in a dozen countries, is opening a branch in France, under the direction of Sophie Demolombe, Research Director at CNRS and co-director of the University Graduate School of […]
Business Landing Nice Côte d’Azur: Support for business set up in France
The Nice Côte d’Azur Metropolis is renewing the financial scheme “Business Landing Nice Côte d’Azur,” which aims to encourage the establishment of new economic activities throughout its territory. The “Business Landing Nice Côte d’Azur” assistance, granted to the company, may range between €30,000 and €50,000, depending on the evaluation of the project submitted by the […]
Biotyks sets up in Nice to develop its solution for managing irritable bowel syndrome
David Macheto, founder and CEO of Biotyks, reveals the story and ambitions of his innovative startup, specialized in defining a personalized diet for irritable bowel syndrome (IBS) through microbiota sequencing. A syndrome that affects 10% of the population. During this interview, David Macheto presents the particularities of his company, but also the significant impact of […]
Team Nice Côte d’Azur in force at Viva Tech 2024
Viva Tech 2024: the must-attend tech event for startups will take place from May 22 to 25 in Paris. 7 gems from the Nice Côte d’Azur metropolis have been selected to present their innovations at the South Region stand (Hall 1 – Stand B30). The Team Nice Côte d’Azur team will participate in this global […]
Entrepreneurship in Research Award 2024
The Nice Côte d’Azur Metropolis launches the Entrepreneurship in Research Prize. As part of its research support policy, the Nice Côte d’Azur Metropolis is committed to promoting the excellence of Côte d’Azur research in the field of entrepreneurship and making it known to the general public. In order to encourage this initiative, it has established […]
New urban health trail in Nice
Inauguration of a new urban health trail in Nice Fabron, strengthening Nice’s commitment to sport and health. The Acti’Santé Nice Fabron loop combines walking, physical exercises, and discovery of the botanical heritage over 2.8 kilometers. The City of Nice Sports-Health House supports this initiative aimed at promoting physical activity for all. Nice continues to demonstrate […]
Quantum Genomics is now the sole holder of all the shares and voting rights of Exactcure
In a press release on April 25, 2024, Quantum Genomics announces that it has obtained the approval of the General Meeting of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of the shares of ExactCure. The company Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC) announces that, […]
